What is the recommendation for initial oral and intravenous antiplatelet therapy in patients with definite or likely NSTE-ACS treated with an initial invasive or ischemia-guided strategy?
 The recommendation for initial oral and intravenous antiplatelet therapy in patients with definite or likely NSTE-ACS treated with an initial invasive or ischemia-guided strategy is to use aspirin and at least one other platelet receptor inhibitor, such as clopidogrel, prasugrel, or ticagrelor. 